FDA Law Blog
DECEMBER 22, 2022
FDA , which held that that banning a single intended use of a specific device was inconsistent with the Federal Food, Drug, and Cosmetic Act’s (“FDC Act”) clear pronouncement that FDA cannot regulate the practice of medicine. This provision represents a complete shift in the way FDA is allowed to regulate products.
Medical Xpress
MAY 9, 2023
An international group of doctors and public health experts have joined the clamor for a moratorium on AI research until the development and use of the technology are properly regulated.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MARCH 16, 2021
European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following a cyberattack. The post Regulators questioned integrity of Pfizer/BioNTech vaccine, leaked files show appeared first on.
pharmaphorum
JANUARY 5, 2021
The regulator made its comments after the UK announced a policy of stretching the gap between doses of the vaccine to up to 12 weeks to ensure maximum coverage of vulnerable groups. The post FDA and doctors warn against extending COVID-19 vaccine dose gap appeared first on. — Sandip Patel MD (@PatelOncology) January 2, 2021.
World of DTC Marketing
AUGUST 7, 2022
First, the health insurance companies are making a lot of money while burying doctors in paperwork and limiting treatment options. Patients and doctors are tired, and insurance companies are raising rates after two years of making a surplus because nobody went to the doctor during the pandemic. The result:?
BioPharma Reporter
JANUARY 25, 2021
The British Medical Association (BMA), the trade union and professional body for doctors in the UK, is calling for the delay between Pfizer/BioNTech COVID-19 vaccine doses to be reduced from 12 weeks to six weeks.
Bio Pharma Dive
MARCH 18, 2022
regulators to authorize another booster shot for people 65 and older, Moderna has followed with a similar request for all adults, arguing a green light would "provide flexibility" to public health officials and doctors. Days after Pfizer asked U.S.
Expert insights. Personalized for you.
114 
Let's personalize your content